ICD112J ;ALB/MJF - YEARLY DRG UPDATE; October 01, 2020@15:42
;;18.0;DRG Grouper;**112**;October 20, 2000;Build 8
;
; Updates for DRGS 640-809
Q
;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
;;640^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC^1.2653^3.4
;;641^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC^0.7702^2.6
;;642^10^MED^INBORN AND OTHER DISORDERS OF METABOLISM^1.4033^3.3
;;643^10^MED^ENDOCRINE DISORDERS WITH MCC^1.6437^5.1
;;644^10^MED^ENDOCRINE DISORDERS WITH CC^1.0191^3.5
;;645^10^MED^ENDOCRINE DISORDERS WITHOUT CC/MCC^0.7426^2.6
;;650^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC^4.6439^6.6
;;651^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC^3.5462^5.6
;;652^11^SURG^KIDNEY TRANSPLANT^3.0851^4.5
;;653^11^SURG^MAJOR BLADDER PROCEDURES WITH MCC^5.5567^10.1
;;654^11^SURG^MAJOR BLADDER PROCEDURES WITH CC^2.8425^5.4
;;655^11^SURG^MAJOR BLADDER PROCEDURES WITHOUT CC/MCC^2.1587^3.4
;;656^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC^3.3053^5.3
;;657^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC^1.8780^2.8
;;658^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC^1.5790^1.8
;;659^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC^2.5769^5.9
;;660^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC^1.4112^3.0
;;661^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC^1.0779^1.8
;;662^11^SURG^MINOR BLADDER PROCEDURES WITH MCC^3.0387^7.0
;;663^11^SURG^MINOR BLADDER PROCEDURES WITH CC^1.5250^3.5
;;664^11^SURG^MINOR BLADDER PROCEDURES WITHOUT CC/MCC^1.1267^1.8
;;665^11^SURG^PROSTATECTOMY WITH MCC^3.0603^7.4
;;666^11^SURG^PROSTATECTOMY WITH CC^1.7219^3.6
;;667^11^SURG^PROSTATECTOMY WITHOUT CC/MCC^0.9839^1.9
;;668^11^SURG^TRANSURETHRAL PROCEDURES WITH MCC^2.8229^7.0
;;669^11^SURG^TRANSURETHRAL PROCEDURES WITH CC^1.5742^3.7
;;670^11^SURG^TRANSURETHRAL PROCEDURES WITHOUT CC/MCC^0.9875^2.0
;;671^11^SURG^URETHRAL PROCEDURES WITH CC/MCC^1.8315^3.7
;;672^11^SURG^URETHRAL PROCEDURES WITHOUT CC/MCC^1.0417^1.6
;;673^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC^3.4940^8.0
;;674^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC^2.3705^6.0
;;675^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC^1.6864^3.0
;;682^11^MED^RENAL FAILURE WITH MCC^1.4866^4.3
;;683^11^MED^RENAL FAILURE WITH CC^0.8949^3.1
;;684^11^MED^RENAL FAILURE WITHOUT CC/MCC^0.6048^2.2
;;686^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC^1.6978^4.7
;;687^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH CC^1.0398^3.2
;;688^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC^0.8664^2.0
;;689^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITH MCC^1.1471^3.8
;;690^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC^0.7956^2.8
;;693^11^MED^URINARY STONES WITH MCC^1.4308^3.7
;;694^11^MED^URINARY STONES WITHOUT MCC^0.7971^2.0
;;695^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC^1.1483^3.6
;;696^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC^0.6930^2.3
;;697^11^MED^URETHRAL STRICTURE^0.9924^2.6
;;698^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC^1.6025^4.8
;;699^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC^1.0121^3.2
;;700^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC^0.7408^2.3
;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES WITH CC/MCC^1.9953^2.3
;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC^1.4847^1.4
;;709^12^SURG^PENIS PROCEDURES WITH CC/MCC^2.4120^4.3
;;710^12^SURG^PENIS PROCEDURES WITHOUT CC/MCC^1.4414^1.9
;;711^12^SURG^TESTES PROCEDURES WITH CC/MCC^2.0434^5.1
;;712^12^SURG^TESTES PROCEDURES WITHOUT CC/MCC^1.2416^2.5
;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY WITH CC/MCC^1.4819^2.6
;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC^0.9582^1.5
;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC^2.2332^5.2
;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC^1.3143^1.5
;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC^1.7703^3.4
;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC^1.2690^1.9
;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC^1.6977^4.9
;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC^1.1524^3.3
;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.7651^1.8
;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY WITH MCC^1.2493^4.0
;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC^0.7716^2.5
;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC^1.4368^4.6
;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC^0.8217^2.9
;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC^1.0778^3.3
;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC^0.6558^2.0
;;734^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC^2.1852^3.4
;;735^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC^1.2722^1.7
;;736^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC^4.2652^8.0
;;737^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC^2.0235^4.0
;;738^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.4038^2.3
;;739^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC^3.9023^6.5
;;740^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC^1.8024^2.7
;;741^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.3129^1.6
;;742^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC^1.8021^2.8
;;743^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC^1.1706^1.6
;;744^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC^1.8983^4.4
;;745^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC^1.1508^2.0
;;746^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC^1.5634^3.3
;;747^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC^0.9786^1.5
;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^1.4172^1.5
;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC^2.5262^5.3
;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC^1.4270^2.1
;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.7369^4.8
;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.0811^3.1
;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.9968^2.1
;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.3722^4.7
;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC^0.9555^3.5
;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6204^2.5
;;760^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC^0.9666^2.6
;;761^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC^0.5657^1.5
;;768^14^SURG^VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C^1.1468^2.8
;;769^14^SURG^POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES^1.6613^2.9
;;770^14^SURG^ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^0.8658^1.6
;;776^14^MED^POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES^0.6971^2.2
;;779^14^MED^ABORTION WITHOUT D&C^1.0186^2.2
;;783^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH MCC^1.9297^4.7
;;784^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH CC^1.0440^3.1
;;785^14^SURG^CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC^0.9121^2.6
;;786^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH MCC^1.6150^4.2
;;787^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH CC^1.0653^3.2
;;788^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC^0.8724^2.7
;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.8258^1.8
;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^6.0211^17.9
;;791^15^MED^PREMATURITY WITH MAJOR PROBLEMS^4.1121^13.3
;;792^15^MED^PREMATURITY WITHOUT MAJOR PROBLEMS^2.4812^8.6
;;793^15^MED^FULL TERM NEONATE WITH MAJOR PROBLEMS^4.2240^4.7
;;794^15^MED^NEONATE WITH OTHER SIGNIFICANT PROBLEMS^1.4951^3.4
;;795^15^MED^NORMAL NEWBORN^0.2024^3.1
;;796^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC^1.3130^3.6
;;797^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC^0.9279^2.1
;;798^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC^0.9279^2.1
;;799^16^SURG^SPLENECTOMY WITH MCC^5.2077^7.6
;;800^16^SURG^SPLENECTOMY WITH CC^2.6585^4.4
;;801^16^SURG^SPLENECTOMY WITHOUT CC/MCC^1.7960^2.6
;;802^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC^3.8120^8.2
;;803^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC^2.0533^4.1
;;804^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC^1.2618^1.8
;;805^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC^1.0056^2.8
;;806^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC^0.6978^2.3
;;807^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC^0.6314^2.0
;;808^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC^2.1410^5.1
;;809^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC^1.2157^3.4
;;EXIT
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD112J 9908 printed Nov 22, 2024@16:57:23 Page 2
ICD112J ;ALB/MJF - YEARLY DRG UPDATE; October 01, 2020@15:42
+1 ;;18.0;DRG Grouper;**112**;October 20, 2000;Build 8
+2 ;
+3 ; Updates for DRGS 640-809
+4 QUIT
+5 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
+1 ;;640^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC^1.2653^3.4
+2 ;;641^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC^0.7702^2.6
+3 ;;642^10^MED^INBORN AND OTHER DISORDERS OF METABOLISM^1.4033^3.3
+4 ;;643^10^MED^ENDOCRINE DISORDERS WITH MCC^1.6437^5.1
+5 ;;644^10^MED^ENDOCRINE DISORDERS WITH CC^1.0191^3.5
+6 ;;645^10^MED^ENDOCRINE DISORDERS WITHOUT CC/MCC^0.7426^2.6
+7 ;;650^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC^4.6439^6.6
+8 ;;651^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC^3.5462^5.6
+9 ;;652^11^SURG^KIDNEY TRANSPLANT^3.0851^4.5
+10 ;;653^11^SURG^MAJOR BLADDER PROCEDURES WITH MCC^5.5567^10.1
+11 ;;654^11^SURG^MAJOR BLADDER PROCEDURES WITH CC^2.8425^5.4
+12 ;;655^11^SURG^MAJOR BLADDER PROCEDURES WITHOUT CC/MCC^2.1587^3.4
+13 ;;656^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC^3.3053^5.3
+14 ;;657^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC^1.8780^2.8
+15 ;;658^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC^1.5790^1.8
+16 ;;659^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC^2.5769^5.9
+17 ;;660^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC^1.4112^3.0
+18 ;;661^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC^1.0779^1.8
+19 ;;662^11^SURG^MINOR BLADDER PROCEDURES WITH MCC^3.0387^7.0
+20 ;;663^11^SURG^MINOR BLADDER PROCEDURES WITH CC^1.5250^3.5
+21 ;;664^11^SURG^MINOR BLADDER PROCEDURES WITHOUT CC/MCC^1.1267^1.8
+22 ;;665^11^SURG^PROSTATECTOMY WITH MCC^3.0603^7.4
+23 ;;666^11^SURG^PROSTATECTOMY WITH CC^1.7219^3.6
+24 ;;667^11^SURG^PROSTATECTOMY WITHOUT CC/MCC^0.9839^1.9
+25 ;;668^11^SURG^TRANSURETHRAL PROCEDURES WITH MCC^2.8229^7.0
+26 ;;669^11^SURG^TRANSURETHRAL PROCEDURES WITH CC^1.5742^3.7
+27 ;;670^11^SURG^TRANSURETHRAL PROCEDURES WITHOUT CC/MCC^0.9875^2.0
+28 ;;671^11^SURG^URETHRAL PROCEDURES WITH CC/MCC^1.8315^3.7
+29 ;;672^11^SURG^URETHRAL PROCEDURES WITHOUT CC/MCC^1.0417^1.6
+30 ;;673^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC^3.4940^8.0
+31 ;;674^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC^2.3705^6.0
+32 ;;675^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC^1.6864^3.0
+33 ;;682^11^MED^RENAL FAILURE WITH MCC^1.4866^4.3
+34 ;;683^11^MED^RENAL FAILURE WITH CC^0.8949^3.1
+35 ;;684^11^MED^RENAL FAILURE WITHOUT CC/MCC^0.6048^2.2
+36 ;;686^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC^1.6978^4.7
+37 ;;687^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH CC^1.0398^3.2
+38 ;;688^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC^0.8664^2.0
+39 ;;689^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITH MCC^1.1471^3.8
+40 ;;690^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC^0.7956^2.8
+41 ;;693^11^MED^URINARY STONES WITH MCC^1.4308^3.7
+42 ;;694^11^MED^URINARY STONES WITHOUT MCC^0.7971^2.0
+43 ;;695^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC^1.1483^3.6
+44 ;;696^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC^0.6930^2.3
+45 ;;697^11^MED^URETHRAL STRICTURE^0.9924^2.6
+46 ;;698^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC^1.6025^4.8
+47 ;;699^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC^1.0121^3.2
+48 ;;700^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC^0.7408^2.3
+49 ;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES WITH CC/MCC^1.9953^2.3
+50 ;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC^1.4847^1.4
+51 ;;709^12^SURG^PENIS PROCEDURES WITH CC/MCC^2.4120^4.3
+52 ;;710^12^SURG^PENIS PROCEDURES WITHOUT CC/MCC^1.4414^1.9
+53 ;;711^12^SURG^TESTES PROCEDURES WITH CC/MCC^2.0434^5.1
+54 ;;712^12^SURG^TESTES PROCEDURES WITHOUT CC/MCC^1.2416^2.5
+55 ;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY WITH CC/MCC^1.4819^2.6
+56 ;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC^0.9582^1.5
+57 ;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC^2.2332^5.2
+58 ;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC^1.3143^1.5
+59 ;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC^1.7703^3.4
+60 ;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC^1.2690^1.9
+61 ;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC^1.6977^4.9
+62 ;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC^1.1524^3.3
+63 ;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.7651^1.8
+64 ;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY WITH MCC^1.2493^4.0
+65 ;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC^0.7716^2.5
+66 ;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC^1.4368^4.6
+67 ;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC^0.8217^2.9
+68 ;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC^1.0778^3.3
+69 ;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC^0.6558^2.0
+70 ;;734^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC^2.1852^3.4
+71 ;;735^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC^1.2722^1.7
+72 ;;736^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC^4.2652^8.0
+73 ;;737^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC^2.0235^4.0
+74 ;;738^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.4038^2.3
+75 ;;739^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC^3.9023^6.5
+76 ;;740^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC^1.8024^2.7
+77 ;;741^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.3129^1.6
+78 ;;742^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC^1.8021^2.8
+79 ;;743^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC^1.1706^1.6
+80 ;;744^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC^1.8983^4.4
+81 ;;745^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC^1.1508^2.0
+82 ;;746^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC^1.5634^3.3
+83 ;;747^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC^0.9786^1.5
+84 ;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^1.4172^1.5
+85 ;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC^2.5262^5.3
+86 ;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC^1.4270^2.1
+87 ;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.7369^4.8
+88 ;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.0811^3.1
+89 ;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.9968^2.1
+90 ;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.3722^4.7
+91 ;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC^0.9555^3.5
+92 ;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6204^2.5
+93 ;;760^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC^0.9666^2.6
+94 ;;761^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC^0.5657^1.5
+95 ;;768^14^SURG^VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C^1.1468^2.8
+96 ;;769^14^SURG^POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES^1.6613^2.9
+97 ;;770^14^SURG^ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^0.8658^1.6
+98 ;;776^14^MED^POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES^0.6971^2.2
+99 ;;779^14^MED^ABORTION WITHOUT D&C^1.0186^2.2
+100 ;;783^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH MCC^1.9297^4.7
+101 ;;784^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH CC^1.0440^3.1
+102 ;;785^14^SURG^CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC^0.9121^2.6
+103 ;;786^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH MCC^1.6150^4.2
+104 ;;787^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH CC^1.0653^3.2
+105 ;;788^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC^0.8724^2.7
+106 ;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.8258^1.8
+107 ;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^6.0211^17.9
+108 ;;791^15^MED^PREMATURITY WITH MAJOR PROBLEMS^4.1121^13.3
+109 ;;792^15^MED^PREMATURITY WITHOUT MAJOR PROBLEMS^2.4812^8.6
+110 ;;793^15^MED^FULL TERM NEONATE WITH MAJOR PROBLEMS^4.2240^4.7
+111 ;;794^15^MED^NEONATE WITH OTHER SIGNIFICANT PROBLEMS^1.4951^3.4
+112 ;;795^15^MED^NORMAL NEWBORN^0.2024^3.1
+113 ;;796^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC^1.3130^3.6
+114 ;;797^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC^0.9279^2.1
+115 ;;798^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC^0.9279^2.1
+116 ;;799^16^SURG^SPLENECTOMY WITH MCC^5.2077^7.6
+117 ;;800^16^SURG^SPLENECTOMY WITH CC^2.6585^4.4
+118 ;;801^16^SURG^SPLENECTOMY WITHOUT CC/MCC^1.7960^2.6
+119 ;;802^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC^3.8120^8.2
+120 ;;803^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC^2.0533^4.1
+121 ;;804^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC^1.2618^1.8
+122 ;;805^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC^1.0056^2.8
+123 ;;806^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC^0.6978^2.3
+124 ;;807^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC^0.6314^2.0
+125 ;;808^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC^2.1410^5.1
+126 ;;809^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC^1.2157^3.4
+127 ;;EXIT
